StemBioSys Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:StemBioSys Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013517
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
StemBioSys Inc (StemBioSys) is a biomedical company that concentrates on isolation, expansion and delivery of specialized adult stem cells. The company has developed high performance microenvironment for treating human diseases. Its HPME is an advanced stem cell culture system that creates natural environment and replicates a 3-dimensional microenvironment which allows stem cells more rapidly with greater preservation of stem cell phenotype than traditional ones. The company’s target therapy areas include diabetes, Parkinson’s disease, Alzheimer’s disease, osteoarthritis, inflammatory disorders and damaged cartilage. StemBioSys is headquartered in San Antonio, Texas, the US.

StemBioSys Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
StemBioSys Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
StemBioSys Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
StemBioSys Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
StemBioSys Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
StemBioSys Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
StemBioSys Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
StemBioSys Raises USD2.7 Million in Venture Financing 10
StemBioSys Raises USD8 Million in Series A Financing 11
StemBioSys Raises US$4.4 Million In Venture Financing 12
Partnerships 13
StemBioSys Enters into Distribution Agreement with SeouLin Bioscience 13
Gencure Enters into Agreement with StemBioSys 14
Cellular Dynamics Enters into Distribution Agreement with Seoulin Bioscience 15
StemBioSys Partners with Cardiovate 16
Licensing Agreements 17
StemBioSys Enters into Licensing Agreement with South Texas Technology Management 17
StemBioSys Inc – Key Competitors 18
StemBioSys Inc – Key Employees 19
StemBioSys Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Government and Public Interest 21
Oct 03, 2016: BioBridge Global-Led Biotech team Awarded $7.8 Million MTEC Contract 21
Other Significant Developments 23
Jan 18, 2017: StemBioSys Announces US and Canadian Distribution Agreement with VWR 23
Aug 02, 2016: Diamyd Medical’s associated company Cellaviva is appointed European distributor for StemBioSys 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
StemBioSys Inc, Pharmaceuticals & Healthcare, Key Facts 2
StemBioSys Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
StemBioSys Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
StemBioSys Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
StemBioSys Inc, Deals By Therapy Area, 2011 to YTD 2017 8
StemBioSys Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
StemBioSys Raises USD2.7 Million in Venture Financing 10
StemBioSys Raises USD8 Million in Series A Financing 11
StemBioSys Raises US$4.4 Million In Venture Financing 12
StemBioSys Enters into Distribution Agreement with SeouLin Bioscience 13
Gencure Enters into Agreement with StemBioSys 14
Cellular Dynamics Enters into Distribution Agreement with Seoulin Bioscience 15
StemBioSys Partners with Cardiovate 16
StemBioSys Enters into Licensing Agreement with South Texas Technology Management 17
StemBioSys Inc, Key Competitors 18
StemBioSys Inc, Key Employees 19
StemBioSys Inc, Other Locations 20
StemBioSys Inc, Subsidiaries 20

★海外企業調査レポート[StemBioSys Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • John Keells Hotels Plc
    John Keells Hotels Plc - Strategy, SWOT and Corporate Finance Report Summary John Keells Hotels Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Breg Inc:医療機器:M&Aディール及び事業提携情報
    Summary Breg Inc (Breg) is a medical device company that manufactures and distributes sports medicine and rehabilitation products. The company offers products such as knee braces, cold therapy, dvt prophylaxis, hip bracing, shoulder bracing, fracture bracing, elbow wrist bracing, spine bracing, foot …
  • GeneNews Ltd (GEN):企業の財務・戦略的SWOT分析
    Summary GeneNews Ltd (GeneNews) is a provider of molecular diagnostic products. The company develops and commercializes diagnostics and personalized medicine for cancer and other chronic diseases. Its Sentinel Principle is a novel approach to identifying biomarkers of body state using blood. GeneNew …
  • Hammerhead Resources Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Hammerhead Resources Inc (Hammerhead Resources), formerly Canadian International Oil Corp is an oil and gas company that offers oilfield services. The company offers services such as acquisition, production, operations, exploration, management, and development of oil and gas assets in North …
  • Adenovir Pharma AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Adenovir Pharma AB (Adenovir Pharma) focuses on the development of antiviral pharmaceutical solutions for the treatment of infectious eye diseases such as adenoviral conjunctivitis and epidemic keratoconjunctivitis (EKC). The company’s APD-209 is topical pharmaceutical product that prevents …
  • Tokyo Printing Ink Mfg Co Ltd (4635)
    Tokyo Printing Ink Mfg Co Ltd (4635) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • TBC Corp:企業の戦略・SWOT・財務情報
    TBC Corp - Strategy, SWOT and Corporate Finance Report Summary TBC Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Printpack, Inc.:企業の戦略・SWOT・財務情報
    Printpack, Inc. - Strategy, SWOT and Corporate Finance Report Summary Printpack, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Jakks Pacific, Inc.:企業の戦略・SWOT・財務分析
    Jakks Pacific, Inc. - Strategy, SWOT and Corporate Finance Report Summary Jakks Pacific, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • McRae Industries, Inc.:企業の戦略・SWOT・財務情報
    McRae Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary McRae Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • DCO Energy LLC-エネルギー分野:企業M&A・提携分析
    Summary DCO Energy LLC (DCO) is an energy development company that constructs, operates, develops, and maintains cogeneration and renewable energy projects across the US. The company's services include financing, performance testing, equipment and systems analyses, retro-commissioning services, ener …
  • Genentech Inc:企業の戦略的SWOT分析
    Genentech Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Bank of Ireland:戦略・SWOT・企業財務分析
    Bank of Ireland - Strategy, SWOT and Corporate Finance Report Summary Bank of Ireland - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Symphony Ltd:企業の戦略・SWOT・財務分析
    Symphony Ltd - Strategy, SWOT and Corporate Finance Report Summary Symphony Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Peyto Exploration & Development Corp (PEY):企業の財務・戦略的SWOT分析
    Summary Peyto Exploration & Development Corp (Peyto Exploration & Development) is an oil and gas exploration and development company that acquires, explores, develops and produces crude oil and unconventional natural gas reserves. The company operates the Alberta Deep Basin, a geologic setting locat …
  • Chromalloy Gas Turbine LLC:企業の戦略・SWOT・財務情報
    Chromalloy Gas Turbine LLC - Strategy, SWOT and Corporate Finance Report Summary Chromalloy Gas Turbine LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • ViaSat Inc:企業の戦略・SWOT・財務情報
    ViaSat Inc - Strategy, SWOT and Corporate Finance Report Summary ViaSat Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • UTair Aviation:企業の戦略・SWOT・財務情報
    UTair Aviation - Strategy, SWOT and Corporate Finance Report Summary UTair Aviation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Optiscan Imaging Limited (OIL)-医療機器分野:企業M&A・提携分析
    Summary Optiscan Imaging Limited (Optiscan) is a technology and product development company. It focuses on the development and application of microscopic imaging technologies for medical procedures. The company’s key product is ViewnVivo, a miniaturized fluorescence endo-microscope platform that bri …
  • Noble Energy Inc (NBL):企業の財務・戦略的SWOT分析
    Noble Energy Inc (NBL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆